The Drug Rebellion Fighting Big Pharma to Save the NHS Millions
May 31, 2017
(New Scientist) – Fleming is one of a growing number of people using buyers’ clubs, which facilitate the unofficial purchase of cheap generic versions of branded drugs, often with tacit help from doctors. Hepatitis C medicines are the newest addition to these grey markets, thanks to the recent development of safe and effective therapies – and the enormous prices they command. But while buyers’ clubs may fill the gap for people like Fleming, is this any way to do medicine in the 21st century? Or is it a sign that we need to fundamentally rethink how we develop and fund new drugs?